Company intelligence / Profile preview

Suzhou Industrial Park Oriental Huaxia Cardiovascular Health Institute

Ownership: Private
Development stage: Other

Overview

Suzhou Industrial Park Oriental Huaxia Cardiovascular Health Institute is an active healthcare research institution based in Suzhou, China. It conducts or sponsors clinical trials related to cardiovascular health. The institute appears to focus on advancing prevention, diagnosis, treatment strategies, and possibly public health initiatives for cardiovascular diseases. There are no publicly available results indicating proprietary drugs or devices developed by this entity as of June 2025.

Therapeutic areas: Cardiovascular
Modalities: Non-pharmacological therapy
Industry: Academic Hospital/University/Research

Beyond the preview

Go deeper on Suzhou Industrial Park Oriental Huaxia Cardiovascular Health Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suzhou Industrial Park Oriental Huaxia Cardiovascular Health Institute.

Explore the full profile